Thus, overall, FGF21 is an insulin-stimulated beneficial myokine that regulates energy metabolism and protects against chronic metabolic disorders such as T2D and obesity. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.